The Impact of Mood Disorders on Adherence, on Life Satisfaction and Acceptance of Illness—Cross-Sectional Observational Study
Authors:
- Alicja JeżuchowskaAJAlicja Jeżuchowska
- Anna Maria CybulskaAnna Maria Cybulska
- Kamila RachubińskaKamila Rachubińska
- Karolina Skonieczna-ŻydeckaKarolina Skonieczna-Żydecka
- Artur ReginiaARArtur Reginia
- Mariusz PanczykMariusz Panczyk
- Dorota ĆwiekDĆDorota Ćwiek
- Elżbieta GrochansEGElżbieta Grochans
- Daria Schneider-MatykaDSDaria Schneider-Matyka
Open Access
- 9 December 2024
- journal article
- research article
- Published by MDPI AG in Healthcare
- Vol. 12 (23) , 2484
Abstract
Background: Mood disorders are among the most prevalent and debilitating mental conditions in worldwide populations. The aim of this study was to identify the factors influencing life satisfaction, disease acceptance, and therapeutic adherence among people with mood disorders. Methods: This survey-based study included 103 people with mood disorders. It was performed using the author questionnaire, and standardized research tools, namely the Adherence to Refills and Medication Scale (ARMS), the Acceptance of Illness Scale (AIS), the Beck Depression Inventory (BDI), and the Satisfaction with Life Scale (SWLS). Results: The level of life satisfaction decreased with the increase in the severity of the depressive symptoms (SE = −0.665, p < 0.001). Mood disorder patients with more severe depressive symptoms had significantly higher scores on the adherence scale (SE = 0.290, p = 0.003). The patients with higher levels of depressive symptoms showed a lower level of acceptance of the disease. Conclusions: 1. The dosage of medications taken, and the severity of the depressive symptoms determine life satisfaction of people with mood disorders. 2. The respondents with a greater severity of depressive symptoms scored higher on the adherence scale, which means that they were more likely to be non-adherent to the treatment recommendations. The type of mood disorder may affect patient adherence. The subjects with bipolar disorder showed higher adherence and those with anxiety–depressive disorder showed a lower adherence than the patients with depression. 3. The subjects with more severe depressive symptoms showed a lower degree of acceptance of the disease.Keywords
This publication has 61 references indexed in Scilit:
- Diagnosis and Treatment of Bipolar DisorderJAMA, 2023
- Psychometric Evaluation of the Depressive Severity Index (DSI) Among Children and Youth Using the interRAI Child and Youth Mental Health (ChYMH) Assessment ToolChild & Youth Care Forum, 2021
- Life satisfaction in persons with mental disordersQuality of Life Research, 2020
- Comparison of Psychosocial Variables Associated With Loneliness in Centenarian vs Elderly Populations in New ZealandJAMA Network Open, 2018
- Dimensionality, Reliability and Validity of the InterRAI Depression Rating Scale in a Canadian Palliative Care PopulationSocial Indicators Research, 2014
- Risk factors for non-adherence to antidepressant treatment in patients with mood disordersEuropean Journal of Clinical Pharmacology, 2013
- The impact of a simple individual psycho-education program on quality of life, rate of relapse and medication adherence in bipolar disorder patientsAsian Journal of Psychiatry, 2013
- Discontinuation of Use and Switching of AntidepressantsJAMA, 2002
- The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health OrganizationSocial Science & Medicine, 1995
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961